Neuroimaging assessment of facility-bound severely-affected MS reveals the critical role of cortical gray matter pathology: results from the CASA–MS case-controlled study-Reference-Cited by-同舟云学术

Neuroimaging assessment of facility-bound severely-affected MS reveals the critical role of cortical gray matter pathology: results from the CASA–MS case-controlled study

Published:2024-05-17 Issue:8 Volume:271 Page:4949-4962
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Zivadinov Robert^ORCID,Jakimovski Dejan,Burnham Alex,Kuhle Jens,Weinstock Zachary,Wicks Taylor R.,Ramanathan Murali,Sciortino Tommaso,Ostrem Mark,Suchan Christopher,Dwyer Michael G.,Reilly Jessica,Bergsland Niels,Schweser Ferdinand,Kennedy Cheryl,Young-Hong David,Eckert Svetlana,Hojnacki David,Benedict Ralph H. B.,Weinstock-Guttman Bianca

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00415-024-12420-2.pdf

Reference45 articles.

1. Arrambide G et al (2020) Aggressive multiple sclerosis (2): treatment. Mult Scler 26:1352458520924595

2. Barnett M et al (2021) Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: the NeuroSTREAM MSBase study. Neuroimage Clin 32:102802

3. Benedict RH, Zivadinov R (2011) Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol 7:332–342

4. Benkert P et al (2022) Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study. Lancet Neurol 21:246–257

5. Benkert P et al. (2023) Serum glial fibrillary acidic protein (GFAP) is a longitudinal indicator of disease progression in MS while neurofilament light chain (NfL) associates with therapy response in patients under B cell depleting therapy. In: MSMilan. Vol., ed.^eds., Milan, Italy